IPHA
USDInnate Pharma S.A. ADS
$1.840-0.040 (-2.128%)
Real-time Price
Healthcare
Biotechnology
France
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$1.880
High
$1.880
Low
$1.840
Volume
0.00M
Company Fundamentals
Market Cap
172.7M
Industry
Biotechnology
Country
France
Trading Stats
Avg Volume
0.02M
Exchange
NMS
Currency
USD
52-Week Range
Low $1.29Current $1.840High $3.511
Related News
BusinessWire
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Regulatory News: Innate Pharma SA (PARIS:IPH, NASDAQ:IPHA) ("Innate" or the "Company") today announced that the Company will hold a conference call on Thursday, November 13, 2025, at 2 p.m. CET / 8 a.m. ET, to give an
View more
Analyst Upgrades
HC Wainwright & Co. Upgrades Innate Pharma to Buy, Announces $5 Price Target
HC Wainwright & Co. analyst Swayampakula Ramakanth upgrades Innate Pharma from Neutral to Buy and announces $5 price target.
View more
Analyst Upgrades
BTIG Reiterates Buy on Innate Pharma, Maintains $8 Price Target
BTIG analyst Justin Zelin reiterates Innate Pharma with a Buy and maintains $8 price target.
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.